Patents Assigned to Johnson & Johnson
  • Patent number: 11890185
    Abstract: A system and method for performing an ocular surgical procedure is provided. The design maintains IOL temperature prior to implantation by assessing a desired IOL temperature, sensing existing IOL temperature, and maintaining the IOL substantially at the desired IOL temperature based at least in part on said existing IOL temperature. The method of maintaining desired IOL temperature involves comparing current IOL temperature with pre-established desired temperature conditions to determine a temperature change. The IOL is maintained substantially at the desired temperature based at least in part on the existing IOL temperature.
    Type: Grant
    Filed: April 22, 2011
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Mark S Cole, Kevin R Springer, Rob Raney
  • Patent number: 11890263
    Abstract: Provided are compositions suitable for treating acne, disrupting a biofilm, and/or killing bacteria contained in a biofilm. Certain compositions comprise a. about 0.1 wt. % to about 7.5 wt. % glycolic acid; b. about 0.1 wt. % to about 5 wt. % gluconolactone; c. about 0.1 wt. % to about 5 wt. % mandelic acid d. a glycol; e. a salt-tolerant thickening polymer, wherein the total amount of glycolic acid, gluconolactone and mandelic acid is less than about 15 wt. % of the total composition.
    Type: Grant
    Filed: August 12, 2021
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Aliaksandr Zhuk, Anthony Geonnotti, Dara Miller, Jennifer Li
  • Patent number: 11891526
    Abstract: Provided are ink compositions for making cosmetic contact lenses, as well as cosmetic contact lenses and methods for their preparation and use. The ink composition comprises: (a) a colorant; and (b) a nonreactive hydrophilic polymer.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Jaqunda Patton, Yong Zhang, Alexander Guzman, Ghulam Maharvi
  • Patent number: 11885706
    Abstract: A method of determining the transmittance of a contact lens (200) includes the steps of obtaining a measurement of a first intensity of electromagnetic radiation reflected by ocular surface (100) with an intensity measuring device (400), positioning the contact lens (200) in direct contact with the ocular surface (100), obtaining a measurement of a second intensity of electromagnetic radiation transmitted through the contact lens (200) that is reflected a region (110) of the ocular surface (100) that is covered by the contact lens (200) with the intensity measuring device (400); and calculating the transmittance using the measurements of the first intensity and the second intensity.
    Type: Grant
    Filed: May 2, 2022
    Date of Patent: January 30, 2024
    Assignees: Transitions Optical, Ltd., Johnson & Johnson Vision Care, Inc.
    Inventors: Forrest R. Blackburn, Joshua Hazle, Patricia Martin
  • Patent number: 11883326
    Abstract: A phacoemulsification system including a phacoemulsification probe having a probe body, a horn disposed at least partially in the probe body, a needle coupled with the horn and configured to be inserted into an eye, and a piezoelectric actuator disposed in the probe body and configured to vibrate the horn and the needle in a first direction with a stroke length with respect to the probe body; a signal generator configured to generate a drive signal to drive a vibration of the piezoelectric actuator; a stroke measurement apparatus configured to provide indications of the stroke length of the needle over time; and a controller configured to dynamically adjust a frequency of the drive signal so as to maximize the stroke length and maintain mechanical resonance of the needle responsively to the provided indications of the stroke length.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: January 30, 2024
    Assignee: JOHNSON & JOHNSON SURGICAL VISION, INC.
    Inventor: Vadim Gliner
  • Patent number: 11878042
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: January 23, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T Holeva
  • Patent number: 11878041
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 1, 2021
    Date of Patent: January 23, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11877953
    Abstract: In one embodiments, a phacoemulsification apparatus includes a phacoemulsification probe including a horn, a needle mounted in the horn and configured for insertion into a lens capsule of a human eye, and a piezoelectric actuator configured to vibrate the horn and the needle and having a resonant frequency, a signal generator configured to generate a drive signal to drive a vibration of the piezoelectric actuator, phase detection circuitry configured to measure a phase difference between: a voltage across the piezoelectric actuator, and a current flowing through the piezoelectric actuator in response to the drive signal, and a controller configured to adjust a frequency of the drive signal so as to minimize the measured phase difference, whereby the piezoelectric actuator vibrates at the resonant frequency.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: January 23, 2024
    Assignee: JOHNSON & JOHNSON SURGICAL VISION, INC.
    Inventors: Assaf Govari, Vadim Gliner
  • Patent number: 11874434
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: January 16, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • Patent number: 11872159
    Abstract: A phacoemulsification surgical console, and a related system and method. The console, system and method may include a cassette receiver suitable for receiving a surgical cassette, a controller suitable for controlling provided aspects of the phacoemulsification; and a pre-alignment feature along a lower portion under and proximate to the cassette receiver, extending outwardly from the lower portion, and suitable for aligning the surgical cassette to the cassette receiver. The pre-alignment feature may comprise a shelf.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: January 16, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventor: Mark W. Ross
  • Patent number: 11869187
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Grant
    Filed: March 10, 2023
    Date of Patent: January 9, 2024
    Assignee: Johnson & Johnson Enterprise Innovation Inc.
    Inventors: George R. Washko, Jr., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Patent number: 11857653
    Abstract: Provided are methods of providing a benefit to the oral cavity by administering to the oral cavity a poorly-soluble calcium compound and subsequently introducing fluoride to the oral cavity.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: January 2, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Daniel Queiroz, Chantel Tester
  • Patent number: 11861823
    Abstract: Disclosed herein are methods for quantifying contact lens deposition. An example method may comprise disposing a contact lens sample in a fluid well. The example method may comprise disposing a volume of tear fluid in the well with the contact lens sample. The example method may comprise capturing pre-rinse images of the contact lens sample. The example method may comprise rinsing the contact lens sample. The example method may comprise capturing post-rinse images of the contact lens after the rinsing. The example method may comprise determining, using one or more of the tear images or the post-rinse images, a deposition metric. The example method may comprise outputting the deposition metric.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: January 2, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Zhenyu Li, Bailin Liang
  • Patent number: 11853013
    Abstract: Described are systems and methods which can be used to indicate the period of time elapsed since the occurrence of a triggering event. More particularly, this application relates to systems and methods which can be used to visually indicate the time period elapsed since an article has been removed from its packaging. The system can include an indicator disposed on or within the article and a trigger disposed within the receptacle and in contact with the indicator. The article may be enclosed within a sealable receptacle of the package. The indicator is responsive to a change in a concentration of the trigger in contact with the indicator.
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: December 26, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frank Gu, Paul Chen
  • Patent number: 11850131
    Abstract: A personal hygiene product with a digital element includes an external personal hygiene product to absorb bodily fluids and a conductive sensor assembly disposed therein. The conductive sensor assembly includes a pair of conductive elements disposed in parallel in a mirrored image about the perimeter of the personal hygiene product and at least one connector directly contacting the pair of conductive elements, said conductive sensor assembly generating a signal indicative of fluid leakage of said personal hygiene product when fluid reaches the area between the pair of conductive elements. The conductive sensor assembly is arranged and configured to communicate with a smart hand held electronic device, either directly or through a wireless connection.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: December 26, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Livea Barbosa, Jose Francisco Cau, Rafael Carniato, Mariana Goulart, William Chester Neeley, Renato Pereira
  • Patent number: D1011194
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: January 16, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1011905
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: January 23, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1013522
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1013523
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1013524
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: February 6, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins